Auron Therapeutics
Focused Team. One Purpose.
- Headquarters
- Newton, Massachusetts
- Employees
- 11–50
- Business Model
- B2B
- Website
- aurontx.com
- Total Funding
- $87.8M
- Last Round
- $27.0M Series BFeb 2025
About
Auron Therapeutics is a patient-centered, platform-powered oncology company developing therapies that target cell-state plasticity — the root driver of cancer and inflammatory disease. Its proprietary AURIGIN platform uses AI and single-cell genomics to identify novel drug targets. Lead program AUTX-703 is in clinical development for AML and other hematologic malignancies.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account